Alex Menys

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

The CONTEXT trial: Real world clinical use of GIQuant-a motility MRI based activity biomarker for small bowel Crohn's disease.

The CONTEXT trial: Real world clinical use of GIQuant-a motility MRI based activity biomarker for small bowel Crohn's disease.

Journal: Journal of Crohn's & colitis

Published: June 10, 2026

Length of the Adult Human Colon in Health and Constipation Measured Using Magnetic Resonance Imaging.

Length of the Adult Human Colon in Health and Constipation Measured Using Magnetic Resonance Imaging.

Journal: Neurogastroenterology and motility

Published: October 07, 2025

pTRACK-generated normalised average T2 signal intensity and fistula volume are accurate and sensitive measures of perianal crohn's disease activity.

pTRACK-generated normalised average T2 signal intensity and fistula volume are accurate and sensitive measures of perianal crohn's disease activity.

Journal: The British journal of radiology

Published: April 14, 2025

pTRACK-generated normalized average T2 signal intensity and fistula volume are accurate and sensitive measures of perianal Crohn's disease activity.

pTRACK-generated normalized average T2 signal intensity and fistula volume are accurate and sensitive measures of perianal Crohn's disease activity.

Journal: The British journal of radiology

Published: April 14, 2025

Magnetic resonance imaging-based ileal motility quantification predicts stricture response to biologic therapy in Crohn's disease.

Magnetic resonance imaging-based ileal motility quantification predicts stricture response to biologic therapy in Crohn's disease.

Journal: Pediatric radiology

Published: March 25, 2025

Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn's Disease Commencing Biological Therapy: The Motility Study.

Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn's Disease Commencing Biological Therapy: The Motility Study.

Journal: Inflammatory bowel diseases

Published: November 26, 2024

Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trial.

Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trial.

Journal: The British journal of radiology

Published: October 24, 2024

MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease.

MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease.

Journal: Insights into imaging

Published: October 17, 2024

Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes.

Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes.

Journal: United European gastroenterology journal

Published: October 03, 2024

A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study.

A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study.

Journal: NIHR open research

Published: August 13, 2024

Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon-in-continuity: A multicenter, open-label, metabolic balance study.

Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon-in-continuity: A multicenter, open-label, metabolic balance study.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: July 26, 2024

Combined MRI, high-resolution manometry and a randomised trial of bisacodyl versus hyoscine show the significance of an enlarged colon in constipation: the RECLAIM study.

Combined MRI, high-resolution manometry and a randomised trial of bisacodyl versus hyoscine show the significance of an enlarged colon in constipation: the RECLAIM study.

Journal: Gut

Published: April 29, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026